U.S. News & World ReportHydroxychloroquine Malaria Drug Didn't Help Virus Patients, Big UK Study Finds U.S. News & World Report - Associated Press Leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized …
Firstpostflipped into FirstPostFamotidine Heartburn drug famotidine may reduce symptoms of non-hospitalised COVID-19 patients, suggests case series - Firstpost Firstpost - Myupchar COVID-19 is a new disease with no known cure yet. In the absence of a specific treatment, doctors have been repurposing various drugs such as the …
IKITOflipped into Healthy LivingMedical Conditions EULAR 2020: Thrombosis risk particularly high for people suffering eurekalert.org - European League Against Rheumatism from rheumatic & musculoskeletal disease activity - Reduced venous thrombosis with TNF inhibitors A current Swedish study came to the result that …
Chicago Tribuneflipped into CoronavirusHydroxychloroquine This time, hardly anyone followed Trump’s lead on virus drugs Chicago Tribune - Ellen Gabler and Michael H. KellerNewly compiled prescription data shows that President Donald Trump’s decision to take an anti-malarial drug to ward off the coronavirus did not inspire many Americans to do the same, reflecting the fast-changing
Daily Mailflipped into Top StoriesHealth (UK) Arthritis drug reduced risks of dying of coronavirus by nearly half dailymail.co.uk - By Mary Kekatos Senior Health Reporter For Dailymail.com A rheumatoid arthritis drug may help improve the conditions of severely ill coronavirus patients, a new study suggests. Tocilizumab, sold under the …
Seeking AlphaInvesting Gilead and Galapagos' filgotinib shows sustained benefit in RA studies (NASDAQ:GILD) Seeking Alpha - Douglas W. House Gilead Sciences (NASDAQ:GILD) and collaboration partner Galapagos NV (NASDAQ:GLPG) announce week 52 results from two Phase 3 clinical trials, FINCH 1 …
